Join
Live feed
·
INSIDERFilingvia Quantisnow
Viracta Therapeutics Inc. logo

Chevallard Daniel R. converted options into 6,889 shares and sold $1,860 worth of shares (3,720 units at $0.50), increasing direct ownership by 3% to 98,822 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VIRX (Viracta Therapeutics Inc.) and more on Quantisnow.